SCHEMBL19743826

SCHEMBL19743826

CCc1cc(Cl)cc(N)c1N

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.41
POLB P06746 2/20 0.41
CYP3A4 P08684 4/20 0.37
ALDH1A1 P00352 4/20 0.36
TSHR P16473 2/20 0.36
ALOX15 P16050 2/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
TDP1 Q9NUW8 1/20 0.36
TAAR1 Q96RJ0 1/20 0.35
TP53 P04637 2/20 0.35
MAPT P10636 3/20 0.34
ABL1 P00519 1/20 0.32
NOS3 P29474 1/20 0.32
NOS1 P29475 1/20 0.32
NOS2 P35228 1/20 0.32
GAA P10253 1/20 0.32
KMT2A Q03164 1/20 0.32
HPGD P15428 1/20 0.32
ALOX12 P18054 1/20 0.32
MAPK1 P28482 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL669840 0.88 HTT (0.50) HTTPOLBCYP3A4ALDH1A1TSHR
SCHEMBL26761192 0.82 CYP3A4 (0.45) HTTPOLBCYP3A4ALDH1A1TSHR
SCHEMBL205507 0.82 HTT (0.41) HTTPOLBCYP3A4ALDH1A1TSHR
SCHEMBL11230051 0.80 CYP3A4 (0.35) HTTPOLBCYP3A4ALDH1A1TSHR
SCHEMBL19785965 0.80 CYP3A4 (0.40) HTTPOLBCYP3A4ALDH1A1TSHR
SCHEMBL11175266 0.80 HTT (0.49) HTTPOLBCYP3A4ALDH1A1TSHR
SCHEMBL9976443 0.78 ALDH1A1 (0.38) HTTPOLBCYP3A4ALDH1A1TSHR
SCHEMBL11139099 0.78 HTT (0.38) HTTPOLBCYP3A4ALDH1A1TSHR
SCHEMBL17744510 0.78 ALDH1A1 (0.40) CYP3A4ALDH1A1TSHRALOX15SMN1; SMN2
SCHEMBL946031 0.78 HTT (0.38) HTTPOLBCYP3A4ALDH1A1TAAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3472154-A1 COMPOUNDS Enterprise Therapeutics Limited (GB) 2019-04-24 EP disclosed
WO-2017221008-A1 COMPOUNDS Enterprise Therapeutics Limited (GB) 2017-12-28 WO disclosed